Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIT45
compared to the current standard of care in postpartum patients.